Dna X (SONM) Change in Receivables (2018 - 2026)

Dna X has reported Change in Receivables for 9 years, with the latest figure at -$250000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 88.91% year-over-year to -$250000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 58.56% YoY), and the FY2025 full-year result was -$181000.0, down 200.0% from the prior year.
• Change in Receivables for Q1 2026 stood at -$250000.0, down from $521000.0 in the prior quarter.
• The five-year high for Change in Receivables was $11.0 million in Q3 2022, with the low at -$11.2 million in Q3 2024.
• Historically, Change in Receivables has averaged $847941.2 across 5 years, with a median of $628000.0 in 2025.
• Annual changes were most pronounced in 2022 — Change in Receivables sank 679.02% — and 2023, when it soared 789.15%.
• Dna X's Change in Receivables stood at $6.1 million in 2022, then plunged by 179.43% to -$4.9 million in 2023, then jumped by 279.32% to $8.8 million in 2024, then sank by 94.05% to $521000.0 in 2025, then tumbled by 147.98% to -$250000.0 in 2026.
• The last three Change in Receivables figures came in at -$250000.0 (Q1 2026), $521000.0 (Q4 2025), and $628000.0 (Q3 2025), per Business Quant data.